logo

CARDICA IN(NSDQ:CRDC)
Cardica, Inc. designs and manufactures proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass graft surgery. In these surgery procedures, veins or arteries are used to construct alternative conduits to restore blood flow beyond narrowed or occluded portions of coronary arteries, bypassing the narrowed or occluded portion of the artery that is impairing blood flow to the heart muscle. Our first two products, the C-Port Distal Anastomosis System, and the PAS-Port Proximal Anastomosis System, provide cardiovascular surgeons with easy-to-use automated systems to perform consistent, rapid and reliable connections, or anastomoses, of the vessels, which surgeons generally view as the most critical aspect of the bypass procedure.
# Employees: 42
Address: 900 Saginaw Drive,Redwood City,CA,USA
Phone: 650 364-9975
Fax: 650 364-3134
Website: www.cardica.com
Email: investors@cardica.com
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Kevin T. Larkin (Chmn.)
Bernard A. Hausen Ph.D. (Presi.; C.E.O.; Chief Medical Off.; Dir.)
Robert Y. Newell (V.P. Fin. & Opera.; C.F.O.)
Douglas T. Ellison (V.P. Sales & Mktg.)
Bryan D. Knodel Ph.D. (V.P. Research and Devept.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/28/2010
Mean EPS (Next Qtr): ($0.15)
Mean EPS (Year): ($0.55)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 3
Shares Performance
Period CRDC Compare to S&P
YTD -67.71 % -73.28 %
4 Weeks -19.34 % -20.21 %
12 Weeks -26.14 % -30.37 %
Shares Information
Analyst Coverage: Y
Avg Volume: 78214
Shares Outstanding: 15M
Market Cap: $0.02B
52 Week High: $4.46
52 Week Low: $1.05
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 CRDC split by factor of 0.250
Earnings Performance
EPS Growth in Last Quarter: 22.73 %
EPS Growth in Last Year: 48.48 %
Sales Growth in Last Quarter: -52.39 %
Sales Growth in Last Quarter: -55.03 %
Financials
Qtr Book Value: $1.26
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: 2.050
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia